Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ADAM17 overexpression
i
Other names:
ADAM17, ADAM Metallopeptidase Domain 17, CSVP, Disintegrin And Metalloproteinase Domain-Containing Protein 17, Tumor Necrosis Factor, Alpha, Converting Enzyme, Snake Venom-Like Protease, TNF-Alpha Convertase, CD156B, TACE, ADAM Metallopeptidase Domain 18, TNF-Alpha Converting Enzyme, TNF-Alpha-Converting Enzyme, CD156b Antigen, ADAM 17, ADAM18, NISBD1, ADAM17, NISBD
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
6868
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ADAM17 overexpression
Ovarian Cancer
ADAM17 overexpression
Ovarian Cancer
bevacizumab
Resistant: B - Late Trials
bevacizumab
Resistant
:
B
bevacizumab
Resistant: B - Late Trials
bevacizumab
Resistant
:
B
ADAM17 overexpression
Colorectal Cancer
ADAM17 overexpression
Colorectal Cancer
oxaliplatin
Resistant: D – Preclinical
oxaliplatin
Resistant
:
D
oxaliplatin
Resistant: D – Preclinical
oxaliplatin
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.